All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

Melanin existed in bacteria, fungi, plants and keratinocytes of skin and hair of animals, catalyzed by tyrosinase, made the surface coloring, which played an important role in protecting the skin and eye from ultraviolet radiation and preventing overheat of internal organization \[[@pone.0138578.ref001],[@pone.0138578.ref002]\]. But overexpression of epidermal pigmentation may lead to some dermatological disorders, such as melasma, freckles, and senile lentigines \[[@pone.0138578.ref003]\].

Tyrosinase, a kind of multifunctional enzyme, mainly contributes to the melanin biosynthesis \[[@pone.0138578.ref004]\]. The enzyme could catalyze two distinct reactions involving the hydroxylation of monophenols and oxidation of diphenols to quinones \[[@pone.0138578.ref005]\]. The quinones could polymerize spontaneously to form macromolecular dark pigments or aggregate with amino acids and proteins to increase brown color of the pigment \[[@pone.0138578.ref006],[@pone.0138578.ref007]\]. In addition, tyrosinase is involved in the process of insect molting, and fresh-keeping of fruits and vegetables \[[@pone.0138578.ref008]--[@pone.0138578.ref010]\]. In recent years, studies of tyrosinase mainly focus on pigment obstructive disease, melanoma, albino, early onset alzheimer\'s disease \[[@pone.0138578.ref011]\]. Therefore, it is of pressing need to acquire new tyrosinase inhibitors from different sources. Hydroquinone, kojic acid, azelaic acid, and arbutin as tyrosinase inhibitors have been applied in pharmaceuticals and cosmetics \[[@pone.0138578.ref012]--[@pone.0138578.ref015]\]. However, hydroquinone is prohibited for its irritation, mutagenesis and cytotoxic effects \[[@pone.0138578.ref016],[@pone.0138578.ref017]\]. The use of kojic acid and arbutin are also limited because of their low efficacy in vivo, unsatisfactory formulation stability, and poor skin penetration \[[@pone.0138578.ref018]\]. Safe and efficient tyrosinase inhibitors will provid theoretical basis for the treatment of pigment disorders and enrich whitening cosmetics markets \[[@pone.0138578.ref019],[@pone.0138578.ref020]\]. Mushroom tyrosinase as a mature model has been widely used in estimating of potential antityrosinase agents \[[@pone.0138578.ref021]\].

The copper ions in the active center of tyrosinase were the central part of catalytic activities of tyrosinase and it were found in the enzyme from different species \[[@pone.0138578.ref022],[@pone.0138578.ref023]\]. So synthesis and screening of antityrosinase agents with copper chelating ability have become current research focus \[[@pone.0138578.ref024],[@pone.0138578.ref025]\]. Heterocyclic compounds containing triazole ring have extensive biological activities such as antibacterial, antispasmodic, anti-inflammatory, especially a large number of derivatives have been synthesized as antibacterial drugs \[[@pone.0138578.ref026],[@pone.0138578.ref027]\]. Because N and S atoms of the compounds played a key role in the coordination of metals at the active site of metalloprotein \[[@pone.0138578.ref028]\], they may have the ability to chelate the copper ions in active center of tyrosinase. So 1,2,4-triazole was widely used as mother nucleus to synthesize a series of special biological molecules, but few applications in the synthesis of tyrosinase inhibitor were reported. The structure of hydroxyl group on the benzene ring is similar to the enzyme substrate which can competitively inhibit the activity of enzyme. Therefore, using 4-Amino-3-hydrazino-5-mercapto-1,2,4-triazole (AHMZ, CAS No.1750-12- 5, the *IC* ~50~ is 32.5 μM), a derivative of triazole, and benzaldehyde as potential moiety to make up a series of new Schiff\'s base molecules and explore their antityrosinase activities is the aims of our current work. The results could provide references for developing tyrosinase inhibitor as addition agent for use in fields of whitening cosmetics or fruit and vegetable preservation.

Materials and Methods {#sec002}
=====================

Materials {#sec003}
---------

The tyrosinase, from mushroom, was bought from Sigma Chemical Co. (St. Louis, MO, USA) and the activity was 6680 U/mg. 4-Amino-3-hydrazino-5-mercapto-1, 2, 4-triazole, 3- hydroxy benzaldehyde, 2- hydroxy benzaldehyde and 3- fluorobenzene formaldehyde were obtained from Aladdin Industrial Co. (Shanghai, China). Other reagents were all analytical grade.

Synthesis {#sec004}
---------

Schiff\'s base derivatives Y~1~, Y~2~, Y~3~ and Y~4~ have been synthesized by reactions between 4-Amino-3-hydrazino-5-mercapto-1,2,4-triazole and benzaldehyde derivatives in ethanol under reflux \[[@pone.0138578.ref029]\]. The products were filtrated and washed several times with ethanol and dried by suction filter. The synthetic procedures were described in [Fig 1](#pone.0138578.g001){ref-type="fig"}.

![Synthetic processes of compound Y~1~, Y~2~, Y~3~ and Y~4~.](pone.0138578.g001){#pone.0138578.g001}

The structures of compounds Y~1~ to Y~4~ were verified by ^1^H NMR, IR and MS. The mass spectroscopy of compounds showed molecular ions peak \[M+H\]^+^.

Enzyme assay {#sec005}
------------

L-Tyr and L-DOPA were used as the substrate to test the monophenolase and diphenolase activities of tyrosinase, respectively \[[@pone.0138578.ref030]\]. The reaction system (3 ml) contained 1.1 mM L-Tyr or 0.5 mM L-DOPA, 25 mM PBS buffer (pH 6.8) and different concentrations of the inhbitors \[[@pone.0138578.ref031]\]. For monophenolase and diphenolase activities, the final concentration of tyrosinase was 33.3μg/ml and 6μg/ml, respectively. The increased optical density with the oxidation of the substrates at 475 nm (the absorption coefficient was 3700 M^−1^cm^−1^) within a certain time were measured by DU800 spectrophotometer \[[@pone.0138578.ref032]\]. IC~50~ was defined as the concentration of inhibitor inhibited 50% of the enzyme activity, which directly reflects the effect of the inhibitors. The Michaelis-Menten constant K~m~ of tyrosinase was determined by Lineweaver-Burk plot with different concentrations of L-DOPA as substrate and the inhibition constants K~I~ and K~IS~ were determined by the secondary plots of the apparent K~m~/V~m~ or 1/V~m~ versus the concentration of the inhibitors \[[@pone.0138578.ref033]\]. The inhibition mechanism was reflected by the plots of 1/v versus 1/\[S\] with various concentrations of mushroom tyrosinase \[[@pone.0138578.ref034]\].

Fluorescence quenching experiments {#sec006}
----------------------------------

Fluorescence quenching means the decrease of fluorescence intensity between the fluorescent molecules and solute molecules. This method was usually used to study the interaction between conformation of protein molecules and small molecules \[[@pone.0138578.ref035]\]. Cary Eclipse fluorescence spectrophotometer was used to record the fluorescence intensities with an excitation wavelength of 280 nm and emission slit widths of 5 nm \[[@pone.0138578.ref033]\]. Y~1~, Y~2~ and Y~3~ do not haven fluorescence phenomenon at the excitation wavelength. In this study, the inhibitor was added in 0.3 mg/ml tyrosinase solution to detect the fluorescence intensity changes and the final concentrations of inhibitor range from 10 to 70 μM.

Copper interaction {#sec007}
------------------

The method to study the relationship between the copper ions and the compounds was similar to that described by Xiao-Xin Chen et al with slight modification \[[@pone.0138578.ref036], [@pone.0138578.ref037]\]. The reaction media include 0.5 mM PBS buffer, 33.3 μM inhibitor solutions and different concentrations of Cu^2+^. The DU800 spectrophotometer was used to record the spectra ranged from 300 nm to 450 nm 30 seconds after the addition of CuSO~4~.

Antioxidant assay {#sec008}
-----------------

ABTS free-radical scavenging assay was used to test the antioxidant capacity of compounds Y~1~ to Y~4~. The method can be found in many articles \[[@pone.0138578.ref038], [@pone.0138578.ref039]\]. 7 mM ABTS and 2.45 mM ammonium persulfate were blended and stored in a dark place 16 hours, and then diluted by 80% ethanol to obtain the working solution which gave an absorbance of 0.69 at 734 nm. The working solution and compounds were mixed and allowed to react for ten minutes, and then measured the absorbance at 734 nm (A~I~) was measured using spectrophotometer. L-ascorbic acid and 80% ethanol was used as a positive and blank control, respectively. The A~0~ value was the blank absorbance. The antioxidant rate (%) = (A~0~-A~I~)/A~0~ \* 100%

Molecular docking {#sec009}
-----------------

The molecular docking technique allows better understanding of the potency of all compounds as inhibitors and the structure and activity relationship. We proceeded to examine the interactions of tyrosinase and compound Y~1~, Y~2~ and Y~3~. In this study, ChemDraw software was used to display the molecular models of the compounds and tyrosinase-inhibitors docking were demonstrated by molecular operation environment software (MOE). The polyphenol oxidase 3 (ppo3, PDB code: 2Y9W) without the structure of the exogenous protein, the PEG and water molecules was used as the protein model \[[@pone.0138578.ref040],[@pone.0138578.ref041]\]. The bonding site of the enzyme in hydrophobic pocket nearby the copper ions was screened by software for the highest score. Before docking, the structure of tyrosinase molecule and ligand were energy minimized by MOE software.

Results {#sec010}
=======

IR, ^1^H NMR and mass spectrometry {#sec011}
----------------------------------

The products were white powders and dissolved in DMSO or water with alkali promoting. The followings were the data of IR, ^1^H NMR and LC-MS spectra of the compounds.

(Z)-4-amino-5-(2-(3-fluorobenzylidene)hydrazinyl)-4H-1,2,4-triazole-3-thiol (Y~1~): IR ([S1 Fig](#pone.0138578.s001){ref-type="supplementary-material"}) (KBr, νmax, cm-1) 3289, 3269(-NH~2~), 3197(-NH), 1648(C = N) ^1^H NMR ([S2 Fig](#pone.0138578.s002){ref-type="supplementary-material"}) (600 MHz, DMSO-d6) δ 10.84 (s, 1H), 8.32 (d, J = 2.3 Hz, 1H), 7.51--7.38 (m, 3H), 7.24--7.07 (m, 1H), 5.53 (d, J = 2.0 Hz, 2H), 5.28 (d, J = 2.1 Hz, 1H); LC-MS (m/z) ([S3 Fig](#pone.0138578.s003){ref-type="supplementary-material"}): observed, 253.35 \[M+H\]^+^; calculated, 252.27 \[M\]^+^.

(Z)-3-((2-(4-amino-5-mercapto-4H-1,2,4-triazol-3-yl)hydrazono)methyl)phenol (Y~2~): IR([S4 Fig](#pone.0138578.s004){ref-type="supplementary-material"}) (KBr, νmax, cm-1) 3351(-OH), 3244, 3200(-NH~2~), 3153(-NH), 1651(C = N) ^1^H NMR ([S5 Fig](#pone.0138578.s005){ref-type="supplementary-material"}) (600 MHz, DMSO-d6) δ 12.94 (s, 1H), 10.60 (s, 1H), 9.53 (s, 1H), 8.23 (s, 1H), 7.21 (t, J = 7.8 Hz, 1H), 7.09 (t, J = 1.9 Hz, 1H), 6.99 (dt, J = 7.6, 1.2 Hz, 1H), 6.77 (ddd, J = 8.1, 2.6, 1.0 Hz, 1H), 5.50 (s, 2H); LC-MS (m/z) ([S6 Fig](#pone.0138578.s006){ref-type="supplementary-material"}): observed, 251.33 \[M+H\]^+^; calculated, 250.28 \[M\]^+^.

(Z)-2-((2-(4-amino-5-mercapto-4H-1,2,4-triazol-3-yl)hydrazono)methyl)phenol (Y~3~): IR ([S7 Fig](#pone.0138578.s007){ref-type="supplementary-material"}) (KBr, νmax, cm-1) 3448(-OH), 3283, 3247(-NH~2~), 3176(-NH), 1646(C = N) ^1^H NMR ([S8 Fig](#pone.0138578.s008){ref-type="supplementary-material"}) (600 MHz, DMSO-d6) δ 13.01 (s, 1H), 11.00 (s, 1H), 10.91 (s, 1H), 8.50 (d, J = 2.1 Hz, 1H), 7.48--7.37 (m, 1H), 7.24 (t, J = 7.7 Hz, 1H), 6.95--6.84 (m, 2H), 5.54 (d, J = 2.1 Hz, 2H); LC-MS (m/z) ([S9 Fig](#pone.0138578.s009){ref-type="supplementary-material"}): observed, 251.33 \[M+H\]^+^; calculated, 250.28 \[M\]+.

3-((Z)-(2-(4-(((E)-3-hydroxybenzylidene)amino)-5-mercapto-4H-1,2,4-triazol-3-yl)hydrazono)methyl)phenol (Y4): IR ([S10 Fig](#pone.0138578.s010){ref-type="supplementary-material"}) (KBr, νmax, cm-1) 3375(-OH), 3187, 3110(-NH2), 3020(-NH), 1637(C = N) 1H NMR ([S11 Fig](#pone.0138578.s011){ref-type="supplementary-material"}) (600 MHz, DMSO-d6) δ 10.68 (s, 1H), 9.98 (s, 1H), 9.84 (s, 1H), 9.57 (s, 1H), 8.25 (s, 1H), 7.45--7.28 (m, 3H), 7.22 (t, J = 7.8 Hz, 1H), 7.13 (t, J = 1.9 Hz, 1H), 7.03 (dt, J = 7.8, 1.7 Hz, 2H), 6.84--6.74 (m, 1H); LC-MS (m/z) ([S12 Fig](#pone.0138578.s012){ref-type="supplementary-material"}): observed, 355.42 \[M+H\]^+^; calculated, 354.39 \[M\]^+^.

Effects of the compounds on mushroom tyrosinase {#sec012}
-----------------------------------------------

L-DOPA as the diphenolase substrate of tyrosinase was used to screen the compounds with good antityrosinase activity. The results showed that compounds Y~1~ to Y~3~ had good inhibitory activity on diphenolase [Fig 2D](#pone.0138578.g002){ref-type="fig"}. Their IC~50~ values were determined to be 12.5, 7.0 and 1.5 μM, respectively. However, compound Y~4~ almost do not have antityrosinase activity. Then the inhibitory effects of the three compounds on monophenolase activity of tyrosinase were also determined. The results for the oxidation of the L-Tyr were shown in [Fig 2AI, 2BI and 2CI](#pone.0138578.g002){ref-type="fig"}, respectively.

![Determinations of the inhibitory activity on monophenolase and diphenolase.\
(**I**) The inhibitory effects on monophenolase activity of mushroom tyrosinase. (**II**) The inhibitory effects on steady-state activity of monophenolase. A, B and C represents the compound Y~1~, Y~2~ and Y~3~ respectively. (**D**) The inhibitory effects on diphenolase activity of mushroom tyrosinase.](pone.0138578.g002){#pone.0138578.g002}

In [Fig 2](#pone.0138578.g002){ref-type="fig"}, curves 0 to 4 expressed the monophenolase kinetics with different concentrations of inhibitors, and the activities of tyrosinase dropped significantly with the concentrations of the inhibitors increasing. After a certain period of time, the reaction slopes were constant and enzyme catalysis reached steady-state. The different slopes represented the stable activity of monophenolase, which reflected the oxidation rates of L-Tyr. The curves of [Fig 2AII, 2BII and 2CII](#pone.0138578.g002){ref-type="fig"} represented the dynamic trend of the steady-state activity of monophenolase with various concentrations of the inhibitors. The concentration of Y~1~, Y~2~ and Y~3~ to decrease half of the steady-state activities of monophenolase was 185, 245 and 95 μM, respectively. The results showed that the inhibitory effects of the compounds on the reaction rates of diphenolase and monophenolase were dose-dependent. A conclusion could be drawnj from [Fig 2](#pone.0138578.g002){ref-type="fig"} that inhibitory effects of inhibitors on diphenolase were higher than that of monophenolase inhibition.

Inhibitory mechanisms, types, and constants of the compounds on mushroom tyrosinase {#sec013}
-----------------------------------------------------------------------------------

Under different concentrations of the enzyme, the residual activity of tyrosinase with a fixed amount of substrate was tested. The results were showed in [Fig 3AI, 3BI and 3CI](#pone.0138578.g003){ref-type="fig"}. The straight lines 1 to 5 all passed through the origin, which indicated that the inhibitory mechanisms of Y~1~, Y~2~ and Y~3~ on tyrosinase activity were reversible.

![Determinations of the inhibitory mechanisms, types, and constants on diphenolase.\
(**I**) The inhibitory mechanisms of the compounds Y~1~ to Y~3~. (**II**) Lineweaver-Burk plots for diphenolase activity. (**III**) The plots of slopes versus the concentrations of the compounds (**IV**) The plots of intercepts versus the concentrations of the compounds.](pone.0138578.g003){#pone.0138578.g003}

In order to explore the inhibitory types of the Schiff\'s bases Y~1~ to Y~3~, the concentration of tyrosinase was kept constant and measured the initial reactions velocity (v~0~) under various concentrations of substrate were measured. A set of straight lines ([Fig 3AII, 3BII and 3CII](#pone.0138578.g003){ref-type="fig"}) of 1/*v* ~0~ versus 1/\[S\] all passed through the second quadrant or third quadrant. The results indicated that the inhibitory types between the inhibitors and tyrosinase were of mixed type including competitive, non-competitive and anti-competitive inhibition. The constants K~I~, for the inhibitor bonding with the free enzymes, were shown in [Fig 3AIII, 3BIII and 3CIII](#pone.0138578.g003){ref-type="fig"}. Furthermore, the constants K~IS~, for the inhibitors bonding with enzyme-substrate complexes, were shown in [Fig 3AIV, 3BIV and 3CIV](#pone.0138578.g003){ref-type="fig"}. K~I~ and K~IS~ were acquired from the straight lines of the slopes and vertical intercepts versus the concentrations of inhibitors, respectively.

KI and K~IS~ Its values of Y~1~, Y~2~ and Y~3~ were determined to be 6.67 and 4 μM, 7.94 and 27.8 μM, 15.47 and 21.04 μM, respectively. The parameters of inhibition were summarized in [Table 1](#pone.0138578.t001){ref-type="table"}.

10.1371/journal.pone.0138578.t001

###### The Inhibition parameters of compounds Y~1~-Y~3~ on tyrosianse.

![](pone.0138578.t001){#pone.0138578.t001g}

  parameters              Y~1~         Y~2~         Y~3~
  ----------------------- ------------ ------------ ------------
  *IC* ~50~(μM)           12.5         7            1.52
  *K* ~I~                 6.67         7.49         15.47
  *K* ~IS~                4            28           21.04
  Inhibition type         Mixed        Mixed        Mixed
  Inhibitory mechanisms   Reversible   Reversible   Reversible

Fluorescence quenching {#sec014}
----------------------

Fluorescence quenching can be divided into static quenching and dynamic quenching. Dynamic quenching is a process, which has energy or electron transfer, while the static quenching process will generate complexes without fluorescence \[[@pone.0138578.ref042]\]. The quenching rate between the fluorescent molecules and quenching agents followed the Stem.Volmer curve equation \[[@pone.0138578.ref043]\]: $$F_{0}/F = 1 + K_{SV}\left\lbrack Q \right\rbrack$$

In the formula, F~0~ is the intensity of fluorescence without quenching agent, F is the fluorescence intensity after adding quencher, K~sv~ (L/mol) represents the relationship of dynamic equilibrium between biological macromolecules and fluorescence quencher molecules after diffusing and colliding, and \[Q\] is the concentration of quencher. From [Fig 4D](#pone.0138578.g004){ref-type="fig"}, the K~sv~ of Y~1~, Y~2~ and Y~3~ was determined to be 94437, 7160983 and 159186 L/mol, respectively. The rate constants of K~s~v \< 100 L/mol in dynamic quenching process indicated that the quenching process was not controlled by diffusion but perhaps a static quenching process which will have an impact on protein secondary structure and physiological activity.

![The fluorescence quenching experiment of compounds.\
**(A, B, C)** Fluorescence absorption phenomena of the compounds. A, B and C represents the compound Y~1~, Y~2~ and Y~3~ respectively. (**D**) The relationship of fluorescence intensity and the concentrations of compounds Y~1~, Y~2~ and Y~3~.](pone.0138578.g004){#pone.0138578.g004}

In addition, the fluorescence intensity decreased and the emission wavelength values slightly increased with the concentration of inhibitors increasing, which further illustrated the generation of complexes between inhibitors and tyrosinase ([Fig 4A, 4B and 4C](#pone.0138578.g004){ref-type="fig"}).

Copper interaction {#sec015}
------------------

Tyrosinase has two copper ions in its active center, which catalyzes the adjacent hydroxylation of monophenol into diphenol and then catalyzes the reaction of diphenol into quinones \[[@pone.0138578.ref044]\]. The whole wavelength scanning experiment detected the bonding ability of the three compounds and copper ions, which was used to infer the intensity of the inhibitors to combine with tyrosinase and reveal inhibitory mechanisms. The results were shown in [Fig 5](#pone.0138578.g005){ref-type="fig"}.

![Absorption spectra for the copper ions interaction with the compounds Y~1~, Y~2~ and Y~3~, respectively.](pone.0138578.g005){#pone.0138578.g005}

As observed in [Fig 5a, 5b and 5c](#pone.0138578.g005){ref-type="fig"}, a new absorption peak was generated at about 380 nm in [Fig 5c](#pone.0138578.g005){ref-type="fig"}, thus only compound Y~3~ could combine with copper ion. A conclusion could be speculated: Y~3~ could combine with the copper ions in the active center of tyrosinase and the ability of the substituted group to chelate the copper ions was related to its location on the benzene ring. And the hypothesis will be further confirmed by molecular docking analysis.

Antioxidant assay {#sec016}
-----------------

Triazole derivatives generally have extensive biological activities, because of its thiol and hydroxyl groups, it may have strong antioxidant activity. With vitamin C (Vc) and AHMZ as control, the antioxidation abilities of the compounds Y~1~ to Y~4~ were assayed and the results were shown in [Fig 6](#pone.0138578.g006){ref-type="fig"}.

![The antioxidant assays of compounds Y~1~ to Y~4~.](pone.0138578.g006){#pone.0138578.g006}

The determination of antioxidant activity achieved the desired results and the properties were dose-dependent. The antioxidant capacities were in the range of Y~1~ \> Y~2~ \> Y~3~ \> Y~4~ \> Vc \> AHMZ. It can be concluded that the combination of A ATMZ and benzaldehyde could improve the antioxidant capacity. This result may be explained by the superimposition effect of reducing groups (hydroxyl, thiol and amino).

Molecular docking {#sec017}
-----------------

Molecular simulations further clarified the underlying mechanisms of compounds in the active center, which would give a more convincing conclusion by combining the results of copper ions mutual effect. [Fig 7](#pone.0138578.g007){ref-type="fig"} depicted the docking conformation of the four compounds in the tyrosinase catalytic center.

![Docking information of compound Y~1~ to Y~4~ in the bonding site of tyrosinase.\
(**A**) The molecular docking process of compound Y~1~. (**I**)The global figure of docking. (**II**)The enlarged figure of docking center. The inhibitor molecule was shown as yellow, while the copper ion was in green. (**III, B, C, D**) the interaction between compound Y~1~ to Y~4~ and the residues of tyrosinase, respectively.](pone.0138578.g007){#pone.0138578.g007}

For the substituent on the benzene ring, only the hydroxyl of compound Y~3~ could interact with the copper ion in the active center of enzyme. Some atoms on compound Y~1~ to Y~3~ act as the acceptor or donor generate hydrogen bonds with the center of tyrosinase. Compound Y~1~ generated hydrogen bonds with His~244~ and Glu~256~, Y~2~ with Glu~256~, His~259~, His~85~, His~94~, Y~3~ with His~244~ and Glu~256~. In addition compound Y~1~ could also form interactions with tyrosinase residues: Ala~286~, His~263~, Phe~264~, Asn~260~, Val~283~, His~94~, His~259~, His~85~, Phe~90~, His~61~, which was shown in [Fig 7AIII](#pone.0138578.g007){ref-type="fig"}. Compound Y~2~ formed interactions with tyrosinase residues: Val~283~, Ser~282~, His~263~, Ala~286~, Phe~292~, His~61~, His~296~, Tyr~97~, Trp~93~, Cys~83~, Phe~90~, Phe~264~, Asn~260~, His~244~, which was shown in [Fig 7B](#pone.0138578.g007){ref-type="fig"}. Compound Y~3~ form interactions with tyrosinase residues: Val~283~, Phe~90~, Asn~260~, His~85~, His~263~, His~94~, His~61~, Phe~292~, Phe~264~, His~296~, Ala~286~, His~259~, Met~257~, with the result was shown in [Fig 7C](#pone.0138578.g007){ref-type="fig"}. Moreover, compound Y~4~ could also form interaction with tyrosinase residues: Val~248~, Val~283~, His~85~, His~259~, His~61~, Phe~292~, Met~280~, Phe~264~, Ala~286~, His~263~, Asn~260~, His~244~, Met~257~, Glu~256~, which was shown in [Fig 7D](#pone.0138578.g007){ref-type="fig"}.

Discussion {#sec018}
==========

The methods of decreasing the activity of melanocytes or avoiding UV radiation all could effectively reduce the accumulation of melanin. However, inhibiting the activities of tyrosinase was most effective when the damage has been done \[[@pone.0138578.ref045],[@pone.0138578.ref046]\]. For the purpose of acquiring efficient antityrosinase agents, we synthesized 10 compounds and 3 from them were found to exhibit antityrosinae activities. This article reported the synthesis of tyrosinase inhibitors and screening on monophenolase and diphenolase of tyrosinase, tested the inhibitory types, mechanisms, fluorescence quenching, copper ions interaction, molecular simulation to further unravel the mechanisms, and its oxidation resistance as a supplement of biological activity.

Compounds Y~1~ to Y~3~ have inhibitory effect on monophenolase and diphenolase activities of mushroom tyrosinase, and the inhibition effects on enzyme were dose-dependent. For monophenolase activity, the compounds suppressed the steady-state activities drastically to decrease the process of enzyme catalysis. For the diphenolase activity, reversible inhibition indicated that the inhibitors suppressed tyrosinase not through reducing the number of the dynamic enzymes. The mixed inhibitory types showed that Y~1~, Y~2~ and Y~3~ suppressed the enzyme activities through bonding with the free enzymes and the enzyme-substrate complexes. Fluorescence quenching results reflected the tyrosinase molecular conformation could be changed by the quencher, which directly showed that tyrosinase could combine with inhibitors to form. The result revealed that the inhibition on tyrosinase did not include the anti-competitive inhibition and the bonding between inhibitors and enzyme may alter the conformations of bonding sites of the substrate to make the bonding difficult or the inhibitor may combine with enzyme-substrate complex and changed the conformation of enzyme to form the inactive inhibitor-enzyme-substrate complexes. Copper ions interaction and molecular docking experiment further exposed the reason of the inhibitory effect on tyrosinase. The inhibition abilitise of the inhibitors on tyrosinase were closely related to the structures of the inhibitors. From the slight difference of molecular structures in the docking information, the following information could be get: the free amino hydrogen on imidazole ring had the potential ability to inhibit the activity of tyrosinase by forming hydrogen bonds with residues of the enzyme active center. The molecular structures of compounds Y~1~ to Y~4~ proved that the inhibitory effects of 2-substitutes on the benzene ring were better than 3-substitutes and hydroxyl substitutes were better than that of fluorine substitutes. In addition, two free amino groups on the imidazole ring connected with two benzene rings respectively, the groups would generate greater steric hindrance and affect the bonding between tyrosinase and inhibitors resulting in reduced inhibitory effect. The differences of structure affect the degree of inhibition on the enzyme and the way of interaction with the enzyme which is in agreement with previous reports \[[@pone.0138578.ref047],[@pone.0138578.ref048]\].

The antioxidant abilities of the compounds Y~1~ to Y~4~ as a supplement of biological activity were assayed. Comparing the differences of molecular structures, the position and type of the substituent on the benzene ring affected the antioxidant capacity. The results that fluorine substitutes were superior to hydroxyl substitutes, and that 3-substituted on the benzene ring were better than 2-substitutes were in contrast to their antityrosinase effects. The antioxidant mechanisms of the compounds are different form their antityrosinase mechanisms, which needs further studies.

In summary, three novel compounds were synthesized as antityrosinase agents. Through many primary determinations, the inhibitors showed effective inhibitory effects on mushroom tyrosinase and the inhibition mechanisms were unraveled. Our current work offered some guidance to the design of novel tyrosinase inhibitors. However, further studies are needed to explore their inhibitory effect on excessive synthesis of melanin, their usage in fresh-keeping, or their other biological activities.

Supporting Information {#sec019}
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